KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Accumulated Expenses: 2009-2014

Historic Accumulated Expenses for Clorox (CLX) over the last 5 years, with Jun 2014 value amounting to $472.0 million.

  • Clorox's Accumulated Expenses fell 3.67% to $472.0 million in Q2 2014 from the same period last year, while for Jun 2014 it was $472.0 million, marking a year-over-year decrease of 3.67%. This contributed to the annual value of $472.0 million for FY2014, which is 3.67% down from last year.
  • According to the latest figures from Q2 2014, Clorox's Accumulated Expenses is $472.0 million, which was down 1.87% from $481.0 million recorded in Q1 2014.
  • Clorox's 5-year Accumulated Expenses high stood at $503.0 million for Q1 2013, and its period low was $425.0 million during Q3 2010.
  • Moreover, its 3-year median value for Accumulated Expenses was $480.5 million (2013), whereas its average is $481.1 million.
  • In the last 5 years, Clorox's Accumulated Expenses fell by 9.98% in 2011 and then rose by 12.56% in 2012.
  • Over the past 5 years, Clorox's Accumulated Expenses (Quarterly) stood at $443.0 million in 2010, then dropped by 1.13% to $438.0 million in 2011, then grew by 12.56% to $493.0 million in 2012, then decreased by 2.64% to $480.0 million in 2013, then decreased by 3.67% to $472.0 million in 2014.
  • Its Accumulated Expenses stands at $472.0 million for Q2 2014, versus $481.0 million for Q1 2014 and $480.0 million for Q4 2013.